A detailed history of Pro Vise Management Group, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 123,111 shares of MDT stock, worth $10.4 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
123,111
Previous 109,506 12.42%
Holding current value
$10.4 Million
Previous $8.62 Million 28.59%
% of portfolio
0.89%
Previous 0.74%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.84 - $91.03 $1.05 Million - $1.24 Million
13,605 Added 12.42%
123,111 $11.1 Million
Q2 2024

Aug 12, 2024

BUY
$78.71 - $87.02 $406,851 - $449,806
5,169 Added 4.95%
109,506 $8.62 Million
Q1 2024

May 09, 2024

BUY
$82.84 - $88.09 $4.07 Million - $4.33 Million
49,123 Added 88.97%
104,337 $9.09 Million
Q4 2023

Feb 09, 2024

BUY
$69.43 - $83.43 $1.11 Million - $1.33 Million
15,923 Added 40.53%
55,214 $4.55 Million
Q3 2023

Nov 08, 2023

BUY
$78.22 - $90.4 $664,557 - $768,038
8,496 Added 27.59%
39,291 $3.08 Million
Q2 2023

Aug 24, 2023

BUY
$79.47 - $91.38 $611,760 - $703,443
7,698 Added 33.33%
30,795 $2.71 Million
Q1 2023

May 05, 2023

BUY
$76.72 - $87.58 $94,825 - $108,248
1,236 Added 5.65%
23,097 $1.86 Million
Q4 2022

Feb 09, 2023

SELL
$76.18 - $87.74 $273,790 - $315,337
-3,594 Reduced 14.12%
21,861 $1.7 Million
Q3 2022

Nov 09, 2022

BUY
$80.75 - $95.31 $311,210 - $367,324
3,854 Added 17.84%
25,455 $2.06 Million
Q2 2022

Aug 08, 2022

BUY
$87.4 - $113.09 $181,267 - $234,548
2,074 Added 10.62%
21,601 $1.94 Million
Q1 2022

Apr 27, 2022

BUY
$100.58 - $112.38 $65,779 - $73,496
654 Added 3.47%
19,527 $2.17 Million
Q4 2021

Jan 18, 2022

BUY
$99.53 - $127.75 $28,067 - $36,025
282 Added 1.52%
18,873 $1.95 Million
Q3 2021

Oct 20, 2021

BUY
$122.75 - $135.17 $1,595 - $1,757
13 Added 0.07%
18,591 $2.33 Million
Q2 2021

Aug 06, 2021

SELL
$118.19 - $131.5 $10,164 - $11,309
-86 Reduced 0.46%
18,578 $2.31 Million
Q1 2021

Apr 22, 2021

BUY
$111.18 - $119.74 $169,549 - $182,603
1,525 Added 8.9%
18,664 $2.21 Million
Q4 2020

Jan 19, 2021

BUY
$100.57 - $117.14 $715,957 - $833,919
7,119 Added 71.05%
17,139 $2.01 Million
Q3 2020

Oct 26, 2020

BUY
$90.13 - $108.78 $503,736 - $607,971
5,589 Added 126.13%
10,020 $1.04 Million
Q2 2020

Aug 07, 2020

BUY
$84.11 - $103.33 $372,691 - $457,855
4,431 New
4,431 $406,000
Q1 2020

May 07, 2020

SELL
$72.92 - $121.3 $133,079 - $221,372
-1,825 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$104.49 - $114.54 $190,694 - $209,035
1,825 New
1,825 $207,000
Q4 2018

Feb 13, 2019

SELL
$85.8 - $99.49 $175,890 - $203,954
-2,050 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$85.91 - $99.17 $34,364 - $39,668
-400 Reduced 16.33%
2,050 $202,000
Q2 2018

Aug 13, 2018

BUY
$77.48 - $87.83 $189,826 - $215,183
2,450 New
2,450 $210,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.